Shiga, Japan-The improvement of interstitial cystitis symptoms with a still-investigational oral agent correlates well with a reduction in bladder platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) expression, suggesting the agent's potential for treating symptoms in patients with nonulcerative IC.
New Products and Services...as reported December 1, 2001
Recent technological advances in small semi-rigid and flexible ureteroscopes, combined with the development of ancillary instruments, have made retrograde ureteroscopy a viable treatment option for calculi in the ureter. This review will present the technique for ureteroscopic treatment of ureteral calculi above and below the iliac vessels.
Toronto-Not unlike many of the patients seen in urology practices, a significant percentage of young infertile men take alternative therapies, some of which may adversely affect their fertility. But many of these men may be hesitant to share this information with you.
New York-A newer monoclonal antibody is showing a canny ability to target prostate cancer cells in both bony and soft tissue, and its therapeutic potential is now undergoing testing. Neil Bander, MD, and colleagues from New York Presbyterian-Weill Cornell Medical Center developed the antibody, dubbed J591 (licensed by BZL Biologics, Inc., Framingham, MA, and sub-licensed by Millennium Pharmaceuticals, Cambridge, MA).
Demands by the public and changing practice patterns in urology are significantly impacting the recertification process for urologists. In this exclusive Urology Times interview, Martin I. Resnick, MD, discusses the changes that will affect all urologists with time-limited certificates. Dr. Resnick is professor and chairman of the department of urology at Case Western Reserve University School of Medicine/University Hospitals, Cleveland, and president-elect of the American Board of Urology. He was interviewed by Richard D. Williams, MD, professor and chairman of the department of urology at the University of Iowa, Iowa City
Baltimore-Nonsteroidal anti-inflammatory drugs may reduce the
risk of prostate cancer, suggests a study completed by Johns Hopkins Hospital
in Baltimore, the National Institute on Aging, and Merck Research Labs.
The researchers stress that the findings are suggestive but not definitive.
Iselin, NJ-The UROSKOP Access fluoroscopic and digital radiographic system
from Siemens Medical Systems, Inc., is a dedicated urodiagnostic table that
offers unrestricted and symmetrical patient access from every side.
Carle Place, NY-Nuclear Associates' Glassers Radiation Protection Eyewear
provides unimpaired peripheral vision. Available with prescription or non-prescription
lenses, the products' extra-large lens area reduces scatter radiation striking
the eye-socket bone structure, the company says. Lenses provide .50-mm lead-equivalent
protection. For added comfort, the eyewear has plastic-reinforced ear rests.
Oak Park, IL-Cunningham Group has launched a new insurance plan that
offers complete protection to medical practices, hospitals, clinics, and
other health care providers that bill Medicare and Medicaid. The new plan,
called MediKey, takes the guesswork out of coding and protects medical earnings
with special low-cost billing errors and omissions (E&O) insurance available
to those who enroll in the compliance plan. This combined approach enables
providers to qualify for the E&O insurance at a favorable rate, the